36 results on '"Cox, Brett W."'
Search Results
2. Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement
3. The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance
4. Prospective Peer Review in Radiation Therapy Treatment Planning: Long-Term Results From a Longitudinal Study
5. Nodular Leptomeningeal Disease—A Distinct Pattern of Recurrence After Postresection Stereotactic Radiosurgery for Brain Metastases: A Multi-institutional Study of Interobserver Reliability
6. Outcomes of a Dose-Escalated Stereotactic Body Radiation Phase 1 Trial for Patients With Low- and Intermediate-Risk Prostate Cancer
7. Five-Year Outcomes of a Phase 1 Dose-Escalation Study Using Stereotactic Body Radiosurgery for Patients With Low-Risk and Intermediate-Risk Prostate Cancer
8. Impact of Multi-Institutional Prospective Peer Review on Target and Organ-at-Risk Delineation in Radiation Therapy
9. Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing
10. Prostate, Seminal Vesicle, Penis, and Urethra
11. Prospective contouring rounds: A novel, high-impact tool for optimizing quality assurance
12. Statin use not associated with improved outcomes in patients treated with brachytherapy for prostate cancer
13. Continuous Monitoring and Intrafraction Target Position Correction During Treatment Improves Target Coverage for Patients Undergoing SBRT Prostate Therapy
14. Establishing High-Quality Prostate Brachytherapy Using a Phantom Simulator Training Program
15. A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy
16. ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer
17. International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition in Spinal Stereotactic Radiosurgery
18. Esophageal Toxicity From High-Dose, Single-Fraction Paraspinal Stereotactic Radiosurgery
19. A comparison of the impact of isotope (125I vs. 103Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer
20. Prostate, Seminal Vesicle, Penis, and Urethra
21. Impact of Increasing Margin Around the Lumpectomy Cavity to Define the Planning Target Volume for 3D Conformal External Beam Accelerated Partial Breast Irradiation
22. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
23. The current state of randomized clinical trial evidence for prostate brachytherapy
24. The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines
25. Decreased PSA nadir as a result of dose-escalated stereotactic body radiation for patients with low- and intermediate-risk prostate cancer.
26. Accuracy evaluation of a six‐degree‐of‐freedom couch using cone beam CT and IsoCal phantom with an in‐house algorithm
27. Preliminary Results of High-Dose Single-Fraction Radiotherapy for the Management of Chordomas of the Spine and Sacrum
28. The NOMS Framework: Approach to the Treatment of Spinal Metastatic Tumors
29. Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients
30. Validation of Real Time Intraoperative Ultrasound-Based Planning for Prostate Brachytherapy with Intraoperative CT-Based Dosimetric Assessment
31. Intraoperative 32P High-Dose Rate Brachytherapy of the Dura for Recurrent Primary and Metastatic Intracranial and Spinal Tumors
32. Comparison of tumor control outcomes and toxicity between LDR brachytherapy and high dose IMRT for clinically localized prostate cancer
33. Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer following primary external beam radiation therapy: Early toxicity results of a prospective study
34. Evolution of a cytokine using DNA family shuffling
35. Intraoperative 32P High-Dose Rate Brachytherapy of the Dura for Recurrent Primary and Metastatic Intracranial and Spinal Tumors.
36. A comparison of the impact of isotope (125I vs. 103Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.